Harm Reduction
The R Street Institute’s Integrated Harm Reduction program is grounded in the understanding that “abstinence only” approaches to behaviors that carry health risks are ineffective at the population level.
The Integrated Harm Reduction team addresses different forms of harm reduction, from tobacco use to sexual health and illicit drugs. The team advances policy research and evidence-based public health solutions to help mitigate the harms associated with these behaviors, while preserving individual liberty and promoting public safety.
OUR ISSUES
latest projects
MEDIA Contact
For general media inquiries and to book our experts, please contact pr@rstreet.org.
SUPPORT US
To support this program, please contact Ginny Mansour, Director of Development, at gmansour@rstreet.org.
Research
commentary
Outreach
Our Scholars
Mazen Saleh
Senior Policy Director, Integrated Harm Reduction
Chelsea Boyd
Resident Research Fellow, Harm Reduction
Stacey McKenna
Resident Senior Fellow, Integrated Harm Reduction
Jessica Shortall
Strategic Partnerships Lead, Integrated Harm Reduction
Harm Reduction in the News
FDA should OK easier access to drug that reverses overdoses
The federal government appears to be on the verge of doing something right for a change—shocking, I know. The Food and Drug Administration (FDA) is mulling a proposal to make certain naloxone products, which reverse drug overdoses, available over-the-counter. The FDA generally doesn’t take such actions lightly—and in fact has a reputation for its long delays. Yet…